Valuation: Quest Laboratories Limited

Market Cap 1.71B 17.94M 15.68M 14.47M 13.38M 25.42M 25.84M 173M 67.84M 841M 67.34M 65.88M 2.91B P/E 2024 *
-
P/E 2025 12.4x
Enterprise Value 1.52B 15.94M 13.94M 12.85M 11.88M 22.58M 22.96M 154M 60.27M 747M 59.83M 58.53M 2.59B EV / Sales 2024 *
-
EV / Sales 2025 1.43x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day+1.42%
1 week-7.44%
Current month-9.28%
1 month-12.01%
3 months-17.48%
6 months-13.17%
Current year-19.16%
1 week 87
Extreme 87
96.5
1 month 87
Extreme 87
122
Current year 87
Extreme 87
152.6
1 year 84
Extreme 84
152.6
3 years 75.15
Extreme 75.15
196.8
5 years 75.15
Extreme 75.15
196.8
10 years 75.15
Extreme 75.15
196.8
Manager TitleAgeSince
Chief Executive Officer 59 01/01/2024
Director of Finance/CFO 38 01/01/2024
Compliance Officer - 03/09/2025
Director TitleAgeSince
Chairman 59 01/01/2024
Director/Board Member 30 05/03/2021
Director/Board Member 72 10/01/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%-7.44%-0.73% - 15.02M
+0.09%+2.12%+56.49%+169.19% 1,084B
-1.63%+2.02%+66.31%+62.70% 634B
-1.12%-0.46%+31.69%+84.44% 447B
+0.18%+2.04%+30.19%+26.51% 330B
-6.22%-3.61%+29.15%+32.09% 295B
-1.27%-0.56%+27.21%+46.39% 285B
-0.93%-1.19%-28.85%-40.38% 218B
-1.19%+0.63%+22.43%+66.30% 199B
-0.72%+7.04%+21.41%+81.19% 169B
Average -0.79%+1.40%+25.53%+58.71% 365.99B
Weighted average by Cap. -0.58%+2.48%+39.76%+84.80%

Financials

2024 2025
Net sales 826M 8.66M 7.57M 6.98M 6.45M 12.27M 12.47M 83.63M 32.74M 406M 32.5M 31.79M 1.41B 1.04B 10.9M 9.53M 8.79M 8.13M 15.45M 15.7M 105M 41.22M 511M 40.92M 40.03M 1.77B
Net income 101M 1.06M 925K 854K 789K 1.5M 1.52M 10.22M 4M 49.63M 3.97M 3.89M 172M 136M 1.42M 1.24M 1.15M 1.06M 2.02M 2.05M 13.74M 5.38M 66.7M 5.34M 5.22M 231M
Net Debt 49.37M 518K 453K 417K 386K 734K 746K 5M 1.96M 24.28M 1.94M 1.9M 84.06M -191M -2M -1.75M -1.61M -1.49M -2.83M -2.88M -19.33M -7.57M -93.81M -7.51M -7.35M -325M
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
50
Date Price Change Volume
09/07/26 INR 89.00 +1.42% 2,400
08/07/26 INR 87.75 -0.28% 18,000
07/07/26 INR 88.00 -3.08% 19,200
06/07/26 INR 90.80 -4.37% 69,600
03/07/26 INR 94.95 +1.28% 50,400
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock